Amgen Inc
Company Profile
Business description
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Contact
One Amgen Center Drive
Thousand Oaks CA 91320-1799
USAT: +1 805 447-1000
E: investor.relations@amgen.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
26,700
Stocks News & Analysis
stocks
2 ASX shares to avoid after results
stocks
Strong results from IPO bolter not enough to change our view
stocks
No sign of AI slowdown for Nvidia
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,316.70 | 53.10 | 0.64% |
| CAC 40 | 7,630.95 | 10.00 | -0.13% |
| DAX 40 | 18,906.92 | 5.65 | -0.03% |
| Dow JONES (US) | 41,563.08 | 228.03 | 0.55% |
| FTSE 100 | 8,376.63 | 3.01 | -0.04% |
| HKSE | 17,989.07 | 202.75 | 1.14% |
| NASDAQ | 17,713.62 | 197.19 | 1.13% |
| Nikkei 225 | 38,647.75 | 285.22 | 0.74% |
| NZX 50 Index | 12,447.68 | 94.07 | 0.76% |
| S&P 500 | 5,648.40 | 56.44 | 1.01% |
| S&P/ASX 200 | 8,091.90 | 46.80 | 0.58% |
| SSE Composite Index | 2,842.21 | 19.11 | 0.68% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Aurizon Holdings Ltd AZJ | 3.38 | 0.00 | 0.00% |
| Latin Resources Ltd LRS | 0.20 | 0.01 | -2.44% |
| Red 5 Ltd RED | 0.34 | 0.02 | 6.25% |
| Droneshield Ltd DRO | 1.33 | 0.09 | 7.29% |
| Mesoblast Ltd MSB | 1.03 | 0.08 | 8.42% |
| Spartan Resources Ltd SPR | 1.46 | 0.16 | 12.36% |
| Telstra Group Ltd TLS | 3.93 | 0.02 | 0.51% |
| Pilbara Minerals Ltd PLS | 2.97 | 0.06 | 2.06% |
| Appen Ltd APX | 1.00 | 0.22 | -17.70% |
| South32 Ltd S32 | 3.14 | 0.04 | 1.29% |